Bottom line
LFSC vs FBDIX: the short answer
LFSC (F/m Emerald Life Sciences Innovation ETF) and FBDIX (Franklin Biotechnology Discovery Fund) are quite different portfolios: only about 18% of their top holdings (by weight) are shared.
But FBDIX is far broader, holding 126 positions to 40 for LFSC, so beyond the top names it adds exposure LFSC doesn't have.
LFSC is cheaper at 0.54% vs 1.01% — a difference of $47 a year per $10,000 invested.
FBDIX has a front-end sales load of up to 5.5%; the other does not.
Updated Nov 19, 2026
LFSC vs FBDIX side by side
| LFSC | FBDIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Rbb | Franklin Templeton |
| Category | Technology Sector | Technology Sector |
| Expense ratio | 0.54% | 1.01% |
| Annual cost per $10k | $54 | $101 |
| 10-yr cost on $10k (prospectus) | $955 | $1,728 |
| Max front load | None | 5.5% |
| 12b-1 fee | 0% | 0.25% |
| 1-yr return | — | +43.9% |
| 5-yr return (annualized) | — | +5.0% |
| 10-yr return (annualized) | — | +6.4% |
| Best quarter | — | +29.5% |
| Worst quarter | — | −24.5% |
| Net assets (fund) | $105.1M | $1.2B |
| Number of holdings | 40 | 126 |
| Portfolio turnover | 19% | 38% |
| Returns as of | — | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
6 of LFSC's top 25 holdings also appear in FBDIX's top 25.
| Holding | LFSC | FBDIX |
|---|---|---|
| Spyre Therapeutics Inc | 6.41% | 1.87% |
| Guardant Health Inc | 5.52% | 2.76% |
| Mirum Pharmaceuticals Inc | 4.92% | 1.98% |
| Cytokinetics Inc | 3.16% | 1.24% |
| Dianthus Therapeutics Inc | 3.09% | 2.32% |
| Bridgebio Pharma Inc | 1.17% | 1.67% |
Source: SEC Form N-PORT
LFSC top 10
- Travere Therapeutics Inc — 7.67%
- Cogent Biosciences Inc — 7.53%
- LivaNova PLC — 7.11%
- Spyre Therapeutics Inc — 6.41%
- Guardant Health Inc — 5.52%
- Mirum Pharmaceuticals Inc — 4.92%
- Corcept Therapeutics Inc — 4.79%
- United Therapeutics Corp — 4.16%
- VeraDermics Inc — 3.42%
- Savara Inc — 3.22%
FBDIX top 10
- Jazz Pharmaceuticals plc — 5.66%
- Amgen, Inc. — 4.39%
- Gilead Sciences, Inc. — 3.86%
- Regeneron Pharmaceuticals, Inc. — 3.77%
- Argenx SE — 3.62%
- Vertex Pharmaceuticals, Inc. — 3.54%
- Franklin Institutional U.S. Government Money Market Fund — 3.18%
- Revolution Medicines, Inc. — 3.01%
- Guardant Health, Inc. — 2.76%
- Ascendis Pharma A/S — 2.56%
FAQ
What is the difference between LFSC and FBDIX?
Which is cheaper, LFSC or FBDIX?
Should I own both LFSC and FBDIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.